BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ASP2957 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ASP2957\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07052929-11064@assetmemo.bio
DTSTAMP:20261121T004042Z
DTSTART;VALUE=DATE:20271031
DTEND;VALUE=DATE:20271101
SUMMARY:ASP2957: Phase 1/2 readout est. (NCT07052929)
DESCRIPTION:ASP2957\, phase 1/2\, X-Linked Myotubular Myopathy.\nStudy: Stu
 dy of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who N
 eed Ventilators\nEstimated primary completion: 31 October 2027. This is a 
 ClinicalTrials.gov estimate\, not a confirmed readout date\, and it can mo
 ve.\nDrug page: https://assetmemo.bio/drug/asp2957#upcoming-events\nRegist
 ry record: https://clinicaltrials.gov/study/NCT07052929
URL:https://assetmemo.bio/drug/asp2957#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07876804-11064@assetmemo.bio
DTSTAMP:20261121T004042Z
DTSTART;VALUE=DATE:20320731
DTEND;VALUE=DATE:20320801
SUMMARY:ASP2957: Phase 1/2 readout est. (NCT07876804)
DESCRIPTION:ASP2957\, phase 1/2\, X-Linked Myotubular Myopathy.\nStudy: A L
 ong-term Follow-up Study in Male Participants With X-linked Myotubular Myo
 pathy Treated With ASP2957\nEstimated primary completion: 31 July 2032. Th
 is is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and i
 t can move.\nDrug page: https://assetmemo.bio/drug/asp2957#upcoming-events
 \nRegistry record: https://clinicaltrials.gov/study/NCT07876804
URL:https://assetmemo.bio/drug/asp2957#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
